These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3690840)

  • 1. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients.
    Austin GE; Mullins RH; Morin LG
    Clin Chem; 1987 Dec; 33(12):2220-4. PubMed ID: 3690840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On glucose transport and non-enzymic glycation of proteins in vivo.
    Hatton MW; Richardson M; Winocour PD
    J Theor Biol; 1993 Apr; 161(4):481-90. PubMed ID: 8412216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.
    Jaleel A; Halvatsiotis P; Williamson B; Juhasz P; Martin S; Nair KS
    Diabetes Care; 2005 Mar; 28(3):645-52. PubMed ID: 15735202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site.
    Shuvaev VV; Fujii J; Kawasaki Y; Itoh H; Hamaoka R; Barbier A; Ziegler O; Siest G; Taniguchi N
    Biochim Biophys Acta; 1999 Aug; 1454(3):296-308. PubMed ID: 10452964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of glycation as a tool for assessing the half-life of proteins.
    Schleicher E; Wieland OH
    Biochim Biophys Acta; 1986 Oct; 884(1):199-205. PubMed ID: 3768412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem diagnosis of diabetic metabolic derangement: elevated alpha 1-antitrypsin and haptoglobin glycosylation levels as an index of antemortem hyperglycemia.
    Ritz S; Mehlan G; Martz W
    J Forensic Sci; 1996 Jan; 41(1):94-100. PubMed ID: 8934703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus.
    Frolov A; Blüher M; Hoffmann R
    Anal Bioanal Chem; 2014 Sep; 406(24):5755-63. PubMed ID: 25074545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Glycation Sites in Blood Plasma Proteins as an Integrated Biomarker of Type 2 Diabetes Mellitus.
    Soboleva A; Mavropulo-Stolyarenko G; Karonova T; Thieme D; Hoehenwarter W; Ihling C; Stefanov V; Grishina T; Frolov A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers.
    Poduslo JF; Curran GL
    Brain Res Mol Brain Res; 1994 Apr; 23(1-2):157-62. PubMed ID: 8028478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study.
    Neelofar K; Arif Z; Alam K; Ahmad J
    Mol Biosyst; 2016 Jul; 12(8):2481-9. PubMed ID: 27226040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits.
    Hatton MW; Southward S; Ross-Ouellet B; Richardson M; Winocour PD
    J Lab Clin Med; 1993 Apr; 121(4):588-97. PubMed ID: 8454941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence.
    Ahmed N; Thornalley PJ
    Biochem J; 2002 May; 364(Pt 1):15-24. PubMed ID: 11988071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
    Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A
    J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker.
    Arasteh A; Farahi S; Habibi-Rezaei M; Moosavi-Movahedi AA
    J Diabetes Metab Disord; 2014; 13():49. PubMed ID: 24708663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic importance of glycation of plasma proteins].
    Beránek M; Palicka V
    Ceska Slov Farm; 1998 Sep; 47(5):211-4. PubMed ID: 9818475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glycation of plasma lipoproteins in diabetic cynomolgus monkeys.
    Wagner JD; Bagdade JD; Litwak KN; Zhang L; Bell-Farrow AD; Wang ZQ; Cefalu WT
    Lab Anim Sci; 1996 Feb; 46(1):31-5. PubMed ID: 8699816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the time-resolved immunofluorometric assay to the study of C3 complement component glycation in vitro and in vivo.
    Gaillard O; Meillet D; Bordas-Fonfrède M; Khalil L; Galli J; Delattre J
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):749-52. PubMed ID: 8305618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycation of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation. Part III: application of proteomic analysis to the manufacture of biological drugs.
    Zheng X; Wu SL; Hancock WS
    Int J Pharm; 2006 Sep; 322(1-2):136-45. PubMed ID: 16920285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-lysine effectively decreases the non-enzymic glycation of proteins in vitro.
    Sensi M; Pricci F; De Rossi MG; Morano S; Di Marlo U
    Clin Chem; 1989 Mar; 35(3):384-7. PubMed ID: 2493343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamylation is a competitor of glycation for protein modification in vivo.
    Nicolas C; Jaisson S; Gorisse L; Tessier FJ; Niquet-Léridon C; Jacolot P; Pietrement C; Gillery P
    Diabetes Metab; 2018 Mar; 44(2):160-167. PubMed ID: 28690125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.